Blog

Majority of pharmaceutical companies are persisting with decade old processes and routines.  They have transactional relationships with suppliers, lack of concerted efforts to progress ahead, and no vision to reap productivity rewards.  The reasons for continuing with these traditional practices include tax regimes, regulatory hurdles, and stable revenues from customers dependent on existing industry offerings.

Disruption—spurred by technological Innovation, fluctuating customer demand patterns,

Supply Chain Management is getting more and more complex.  The pressure on the Supply Chain information to be made public is also increasing day by day.  With the popularity and widespread use of social media, it has become more and more difficult for organizations to hide information pertaining to supply chain practices, employees’ treatment, suppliers’ processes, or waste materials generated that could affect the environment.  Social media often publicizes negative reports on companies’ supply

Reducing the fragility of global Supply Chains in the event of disruption through natural or other disasters is a major concern for most senior executives.  This rings true more so now than ever, as the world grapples with COVID-19, the worst human health crisis in 100 years.

The strategies to enhance the effectiveness and readiness level of Supply Chains and to reduce risks associated with disruption come with a price.  These costs are critical to build Supply Chain Resilience across all industr

Supply Chains often get disrupted by calamities that are beyond human control.  Natural disasters, such as tsunamis and floods, in the last decade have drastically affected major businesses—from automobiles to technology, to travel, to shipments—and exposed critical weaknesses in Supply Chain mechanisms around the globe.  And, now, we are living through a global disruption of an unparalleled nature, COVID-19.

Organizations that rely on single-source suppliers, common parts, and centralized invent